Modular Medical Files 10-Q Amendment
Ticker: MODD · Form: 10-Q/A · Filed: Nov 27, 2024 · CIK: 1074871
Sentiment: neutral
Topics: filing-amendment, 10-Q, SEC
TL;DR
Modular Medical filed an amendment to their Q3 10-Q. Check for updates.
AI Summary
Modular Medical, Inc. filed an amendment (Amendment No. 1) to its Form 10-Q for the quarterly period ended September 30, 2024. This filing is an update to their previous report, indicating adjustments or additional information being provided to the SEC regarding their financial status and operations for that period.
Why It Matters
This amendment signals that Modular Medical is providing updated or corrected information to the SEC, which could be material for investors assessing the company's financial health and operational status.
Risk Assessment
Risk Level: medium — Amendments to SEC filings can indicate previously undisclosed issues or corrections, requiring closer scrutiny by investors.
Key Numbers
- 000-49671 — Commission File Number (Identifies Modular Medical, Inc. in SEC filings.)
Key Players & Entities
- Modular Medical, Inc. (company) — Filer of the 10-Q/A
- September 30, 2024 (date) — Quarterly period end date for the 10-Q filing
- 20241127 (date) — Filing date of the amendment
- 000-49671 (company) — Commission file number for Modular Medical, Inc.
FAQ
What specific information is being amended in this 10-Q filing?
The provided text is the cover page of the amendment and does not detail the specific changes made to the original 10-Q. A review of the full amended filing would be necessary to identify the exact amendments.
What is the primary purpose of filing a 10-Q/A?
A 10-Q/A (Amendment No. 1 to Form 10-Q) is filed to correct or supplement information previously reported in a Form 10-Q filing.
What period does this amended 10-Q report cover?
This amended 10-Q report covers the quarterly period ended September 30, 2024.
When was this amendment filed with the SEC?
This amendment was filed on November 27, 2024.
What is Modular Medical, Inc.'s principal executive office address?
Modular Medical, Inc.'s principal executive offices are located at 10740 Thornmint Road, San Diego, CA 92127.
Filing Stats: 902 words · 4 min read · ~3 pages · Grade level 13 · Accepted 2024-11-27 16:55:39
Key Financial Figures
- $0.001 — he registrant's common stock, par value $0.001 per share, was 34,571,939 as of Novembe
Filing Documents
- ea0222929-10qa1_modular.htm (10-Q/A) — 34KB
- ea022292901ex31-1_modular.htm (EX-31.1) — 9KB
- ea022292901ex31-2_modular.htm (EX-31.2) — 9KB
- ea022292901ex32-1_modular.htm (EX-32.1) — 4KB
- 0001213900-24-103547.txt ( ) — 222KB
- modd-20240930.xsd (EX-101.SCH) — 3KB
- modd-20240930_lab.xml (EX-101.LAB) — 26KB
- modd-20240930_pre.xml (EX-101.PRE) — 14KB
- ea0222929-10qa1_modular_htm.xml (XML) — 5KB
Exhibits
Item 6. Exhibits Exhibit Reference Filed or Furnished Number Exhibit Description Form Exhibit Filing Date Herewith 31.1 Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 31.2 Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 32.1 Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 101 The following financial information from Modular Medical, Inc.'s quarterly report on Form 10-Q for the period ended September 30, 2024, filed with the SEC on November 13, 2024, formatted in Inline Extensible Business Reporting Language (Inline XBRL): (i) the Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2024 and 2023, (ii) the Condensed Consolidated Balance Sheets as of September 30 2024 and March 31, 2024, (iii) the Condensed Consolidated Statements of Stockholders' Equity for the three and six months ended September 30, 2024 and 2023, (iv) the Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2024 and 2023, and (v) Notes to Condensed Consolidated Financial Statements. X 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). X 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MODULAR MEDICAL, INC. Date: November 27, 2024 By: /s/ James E. Besser James E. Besser Chief Executive Officer (Principal Executive Officer) By: /s/ Paul DiPerna Paul DiPerna Chairman, President, Chief Financial Officer and Treasurer (Principal Financial Officer) 2